Mangalam Drugs & Organics's quarterly market cap
declined
from Jun. 2023 (₹1,724 Mil) to Sep. 2023 (₹1,655 Mil) and
declined
from Sep. 2023 (₹1,655 Mil) to Dec. 2023 (₹1,554 Mil).
Mangalam Drugs & Organics's annual market cap
declined
from Mar. 2022 (₹1,628 Mil) to Mar. 2023 (₹1,549 Mil) and
declined
from Mar. 2023 (₹1,549 Mil) to Mar. 2024 (₹1,466 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Mangalam Drugs & Organics's Enterprise Value for Today is ₹2,475 Mil.
Mangalam Drugs & Organics Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Mangalam Drugs & Organics's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Mangalam Drugs & Organics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mangalam Drugs & Organics's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mangalam Drugs & Organics's Market Cap distribution charts can be found below:
* The bar in red indicates where Mangalam Drugs & Organics's Market Cap falls into.
Mangalam Drugs & Organics Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mangalam Drugs & Organics (BOM:532637) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Mangalam Drugs & Organics Market Cap Related Terms
Thank you for viewing the detailed overview of Mangalam Drugs & Organics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Mangalam Drugs & Organics (BOM:532637) Business Description
Mangalam Drugs & Organics Ltd is an Indian company operating in the healthcare sector. It is engaged in the research and development and manufacturing of drugs. Its product range includes Active Pharmaceutical Ingredients (APIs), Intermediates, and Specialty chemicals. Its sales comprise of sales in the Indian and overseas markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:532637 has been successfully added to your 